Palmoplantar pustulosis with fulminant dystrophic 20-nail psoriasis in a patient receiving adalimumab therapy

J Drugs Dermatol. 2013 Jan;12(1):16-7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Anti-Inflammatory Agents / adverse effects*
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Crohn Disease / complications
  • Crohn Disease / drug therapy
  • Exanthema / etiology
  • Exanthema / pathology
  • Female
  • Humans
  • Middle Aged
  • Nail Diseases / pathology*
  • Nails / pathology
  • Paronychia / complications
  • Pruritus / complications
  • Pruritus / etiology
  • Psoriasis / chemically induced*
  • Psoriasis / complications*
  • Psoriasis / pathology
  • Skin / pathology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Adalimumab